BioCentury
ARTICLE | Clinical News

Neublastin artemin/enovin: Phase I started

September 7, 2009 7:00 AM UTC

Biogen Idec began a single-blind, placebo-controlled, dose-escalation, Australian Phase I trial to evaluate single doses of IV Neublastin in 28 patients. The trial start triggers an undisclosed milest...